About GGHSX
Invesco Health Care Fund Class R6 is a mutual fund focused on achieving long-term capital growth by investing primarily in equity securities of health care companies worldwide. The fund targets industry leaders and innovators across various segments within the health care sector, including health care equipment, biotechnology, pharmaceuticals, distributors, and managed care. As of the most recent data, the portfolio is heavily weighted toward U.S. companies, with additional exposure to select international markets such as the Netherlands, Switzerland, and the United Kingdom. The fund typically maintains a diversified basket of large-cap health care firms, emphasizing entities with strong management and a history of leadership in their subsectors. With an annual turnover rate around 56%, the fund actively manages its holdings to capitalize on emerging trends and shifts within the global health care industry. The Class R6 share class is structured for institutional investors and comes with a competitive expense ratio, supporting strategies that seek to balance risk with the potential for robust, long-term returns. In the broader financial market, the fund serves as a specialized vehicle for those seeking concentrated exposure to the evolving health care sector, a critical component of the global economy.
Fund Family Invesco
Category Health
Performance Rating Average
Risk Rating Average
Stock Exchange NASDAQ
Ticker Symbol GGHSX
Index S&P Composite 1500 Health Care TR
GGHSX had a total return of 19.55% in the past year, including dividends. Since the fund's
inception, the average annual return has been 8.63%.
